TreeWAS – Variant ID: rs137115

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.917	0.083
C79 Secondary malignant neoplasm of other sites	0.000	0.924	0.076
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.926	0.074
C79.6 Secondary malignant neoplasm of ovary	0.000	0.931	0.069
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.934	0.066
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.941	0.059
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.949	0.051
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.950	0.049
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.956	0.044
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.957	0.043
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.962	0.038
C78.0 Secondary malignant neoplasm of lung	0.000	0.963	0.037
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.964	0.036
C77.3 Axillary and upper limb lymph nodes	0.000	0.968	0.032
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.969	0.031
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.969	0.031
C76.2 Abdomen	0.000	0.970	0.030
C76.3 Pelvis	0.000	0.970	0.030
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.970	0.030
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.971	0.029
C78.7 Secondary malignant neoplasm of liver	0.000	0.971	0.029
C79.2 Secondary malignant neoplasm of skin	0.000	0.971	0.028
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.972	0.028
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.973	0.027
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.973	0.027
C77.9 Lymph node, unspecified	0.000	0.974	0.026
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.974	0.026
C76.7 Other ill-defined sites	0.000	0.974	0.026
C76.5 Lower limb	0.000	0.974	0.026
C76.4 Upper limb	0.000	0.974	0.026
C76.0 Head, face and neck	0.000	0.976	0.024
C76.1 Thorax	0.000	0.976	0.024
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.977	0.023
C77.0 Lymph nodes of head, face and neck	0.000	0.978	0.022
C78.2 Secondary malignant neoplasm of pleura	0.000	0.980	0.020
C80 Malignant neoplasm without specification of site	0.000	0.981	0.019
C77.8 Lymph nodes of multiple regions	0.000	0.982	0.018
C77.4 Inguinal and lower limb lymph nodes	0.000	0.982	0.018
D47.1 Chronic myeloproliferative disease	0.017	0.983	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.017	0.983	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.016	0.984	0.000
D47.2 Monoclonal gammopathy	0.015	0.985	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.985	0.015
N99.2 Postprocedural adhesions of vagina	0.000	0.986	0.014
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.986	0.014
D47.4 Osteomyelofibrosis	0.014	0.986	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.987	0.013
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.013	0.987	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.012	0.987	0.000
N99.1 Postprocedural urethral stricture	0.000	0.988	0.012
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.012	0.988	0.000
C80.9 Malignant neoplasm, unspecified	0.000	0.988	0.012
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.012	0.988	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.988	0.012
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.988	0.012
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.989	0.011
N99.5 Malfunction of external stoma of urinary tract	0.000	0.989	0.011
N99.0 Postprocedural renal failure	0.000	0.989	0.011
D68.2 Hereditary deficiency of other clotting factors	0.011	0.989	0.000
R59.1 Generalised enlarged lymph nodes	0.010	0.990	0.000
C77.5 Intrapelvic lymph nodes	0.000	0.990	0.009
Y57.5 X-ray contrast media	0.009	0.991	0.000
N20.2 Calculus of kidney with calculus of ureter	0.009	0.991	0.000
Y52 Agents primarily affecting the cardiovascular system	0.009	0.991	0.000
Y57 Other and unspecified drugs and medicaments	0.009	0.991	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.009	0.991	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.008	0.992	0.000
Y57.9 Drug or medicament, unspecified	0.008	0.992	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
E22.0 Acromegaly and pituitary gigantism	0.008	0.992	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.008	0.992	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.008	0.992	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.008	0.992	0.000
Y53.4 Other laxatives	0.008	0.992	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.008	0.992	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.007	0.993	0.000
C71.9 Brain, unspecified	0.007	0.993	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.007	0.993	0.000
K62.9 Disease of anus and rectum, unspecified	0.000	0.993	0.007
C71 Malignant neoplasm of brain	0.007	0.993	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.993	0.000
C71.1 Frontal lobe	0.007	0.993	0.000
Y52.1 Calcium-channel blockers	0.007	0.993	0.000
E22 Hyperfunction of pituitary gland	0.007	0.993	0.000
Y53.2 Stimulant laxatives	0.007	0.993	0.000
Y53.6 Antidiarrhoeal drugs	0.007	0.993	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.007	0.993	0.000
C77.2 Intra-abdominal lymph nodes	0.000	0.993	0.007
Y58 Bacterial vaccines	0.007	0.993	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.993	0.007
C71.2 Temporal lobe	0.007	0.993	0.000
Y54.8 Agents affecting uric acid metabolism	0.007	0.993	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.006	0.993	0.000
Y53.3 Saline and osmotic laxatives	0.006	0.993	0.000
Y57.7 Vitamins, not elsewhere classified	0.006	0.993	0.000
Y57.4 Pharmaceutical excipients	0.006	0.993	0.000
Y57.3 Alcohol deterrents	0.006	0.993	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.006	0.993	0.000
Y57.1 Lipotropic drugs	0.006	0.993	0.000
Y57.0 Appetite depressants [anorectics]	0.006	0.993	0.000
Y54.5 Other diuretics	0.006	0.993	0.000
Y54.4 Loop [high-ceiling] diuretics	0.006	0.994	0.000
Y44 Agents primarily affecting blood constituents	0.006	0.994	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
Y53.7 Emetics	0.006	0.994	0.000
Y53.5 Digestants	0.006	0.994	0.000
Y53.0 Histamine H2-receptor antagonists	0.006	0.994	0.000
C71.8 Overlapping lesion of brain	0.006	0.994	0.000
C71.0 Cerebrum, except lobes and ventricles	0.006	0.994	0.000
Y52.7 Peripheral vasodilators	0.006	0.994	0.000
Y56.3 Emollients, demulcents and protectants	0.006	0.994	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.006	0.994	0.000
Y57.8 Other drugs and medicaments	0.006	0.994	0.000
D68 Other coagulation defects	0.006	0.994	0.000
D68.5 Primary Thrombophilia	0.006	0.994	0.000
Y57.6 Other diagnostic agents	0.006	0.994	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.006	0.994	0.000
N99-N99 Other disorders of the genitourinary system	0.000	0.994	0.006
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
Y58.0 BCG vaccine	0.006	0.994	0.000
Y54.3 Benzothiadiazine derivatives	0.006	0.994	0.000
Y54.0 Mineralocorticoids	0.006	0.994	0.000
Y54.9 Mineral salts, not elsewhere classified	0.006	0.994	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.006	0.994	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.006	0.994	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
Y56.9 Topical agent, unspecified	0.006	0.994	0.000
Y56.8 Other topical agents	0.006	0.994	0.000
Y56.7 Dental drugs, topically applied	0.006	0.994	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.006	0.994	0.000
Y56.5 Ophthalmological drugs and preparations	0.006	0.994	0.000
Y56.2 Local astringents and local detergents	0.006	0.994	0.000
Y56.1 Antipruritics	0.006	0.994	0.000
D46 Myelodysplastic syndromes	0.006	0.994	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.006	0.994	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.994	0.000
N35.9 Urethral stricture, unspecified	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.005	0.994	0.000
C71.4 Occipital lobe	0.005	0.994	0.000
Y54.7 Agents affecting calcification	0.005	0.994	0.000
C71.5 Cerebral ventricle	0.005	0.994	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.005	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.995	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.005	0.995	0.000
C71.6 Cerebellum	0.005	0.995	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.005	0.995	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.995	0.005
E22.8 Other hyperfunction of pituitary gland	0.005	0.995	0.000
Y44.5 Thrombolytic drugs	0.005	0.995	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.005	0.995	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.005	0.995	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.005	0.995	0.000
Y40.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
Y58.9 Other and unspecified bacterial vaccines	0.005	0.995	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.005	0.995	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.005	0.995	0.000
Y58.5 Diphtheria vaccine	0.005	0.995	0.000
Y58.4 Tetanus vaccine	0.005	0.995	0.000
Y58.3 Plague vaccine	0.005	0.995	0.000
Y58.2 Cholera vaccine	0.005	0.995	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
C71.3 Parietal lobe	0.005	0.995	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.005	0.995	0.000
Y44.7 Plasma substitutes	0.005	0.995	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.005	0.995	0.000
M84.04 Malunion of fracture (Hand)	0.000	0.995	0.005
D68.8 Other specified coagulation defects	0.005	0.995	0.000
E22.1 Hyperprolactinaemia	0.005	0.995	0.000
I21.4 Acute subendocardial myocardial infarction	0.005	0.995	0.000
Y44.2 Anticoagulants	0.005	0.995	0.000
D48.5 Skin	0.005	0.995	0.000
Y40 Systemic antibiotics	0.005	0.995	0.000
Y44.6 Natural blood and blood products	0.005	0.995	0.000
D68.1 Hereditary factor XI deficiency	0.005	0.995	0.000
D48.7 Other specified sites	0.005	0.995	0.000
D46.1 Refractory anaemia with sideroblasts	0.005	0.995	0.000
D68.4 Acquired coagulation factor deficiency	0.005	0.995	0.000
Y46.5 Valproic acid	0.005	0.995	0.000
D68.6 Other Thrombophilia	0.005	0.995	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.995	0.000
Y55.0 Oxytocic drugs	0.004	0.995	0.000
D48.0 Bone and articular cartilage	0.005	0.995	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.004	0.995	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.004	0.996	0.000
Y46.2 Hydantoin derivatives	0.004	0.996	0.000
C71.7 Brain stem	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
D68.0 Von Willebrand's disease	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
D46.4 Refractory anaemia, unspecified	0.004	0.996	0.000
Y46.6 Other and unspecified antiepileptics	0.004	0.996	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.004	0.996	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.004	0.996	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.004	0.996	0.000
Y46.8 Antispasticity drugs	0.004	0.996	0.000
Y46.3 Deoxybarbiturates	0.004	0.996	0.000
Y46.1 Oxazolidinediones	0.004	0.996	0.000
Y46.0 Succinimides	0.004	0.996	0.000
D48.3 Retroperitoneum	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.004	0.996	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
D46.7 Other myelodysplastic syndromes	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.004	0.996	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.004	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.004	0.996	0.000
Y47.4 Bromine compounds	0.004	0.996	0.000
Y47.3 Paraldehyde	0.004	0.996	0.000
Y47.2 Chloral derivatives	0.004	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y59.3 Immunoglobulin	0.004	0.996	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y46.4 Iminostilbenes	0.004	0.996	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.004	0.996	0.000
D48.4 Peritoneum	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y41.0 Sulphonamides	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
D45 Polycythaemia vera	0.004	0.996	0.000
D46.2 Refractory anaemia with excess of blasts	0.004	0.996	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.004	0.996	0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.004	0.996	0.000
Y40.0 Penicillins	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y43.4 Immunosuppressive agents	0.004	0.996	0.000
Y40.2 Chloramphenicol group	0.003	0.996	0.000
Y47.1 Benzodiazepines	0.003	0.996	0.000
D38.5 Other respiratory organs	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
D48.6 Breast	0.004	0.996	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.004	0.996	0.000
Y40.5 Aminoglycosides	0.003	0.996	0.000
Y40.6 Rifamycins	0.003	0.996	0.000
D43.4 Spinal cord	0.003	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
D42.9 Meninges, unspecified	0.003	0.997	0.000
Z71.3 Dietary counselling and surveillance	0.003	0.997	0.000
D40.0 Prostate	0.003	0.997	0.000
D43.0 Brain, supratentorial	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.003	0.997	0.000
D40.1 Testis	0.003	0.997	0.000
D42.1 Spinal meninges	0.003	0.997	0.000
D42.0 Cerebral meninges	0.003	0.997	0.000
D40.9 Male genital organ, unspecified	0.003	0.997	0.000
D40.7 Other male genital organs	0.003	0.997	0.000
D48.1 Connective and other soft tissue	0.003	0.997	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.003	0.997	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
D43.9 Central nervous system, unspecified	0.003	0.997	0.000
D43.7 Other parts of central nervous system	0.003	0.997	0.000
D43.3 Cranial nerves	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.003	0.997	0.000
D38.6 Respiratory organ, unspecified	0.003	0.997	0.000
D38.4 Thymus	0.003	0.997	0.000
D38.2 Pleura	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
M84.0 Malunion of fracture	0.000	0.997	0.003
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Z71.2 Person consulting for explanation of investigation findings	0.003	0.997	0.000
T40.2 Other opioids	0.000	0.997	0.003
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
D38.0 Larynx	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.003	0.997	0.000
O62.2 Other uterine inertia	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
X62.9 Unspecified place	0.000	0.997	0.003
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.997	0.003
M84.02 Malunion of fracture (Upper arm)	0.000	0.997	0.003
D38.1 Trachea, bronchus and lung	0.003	0.997	0.000
D41.1 Renal pelvis	0.003	0.997	0.000
D43.2 Brain, unspecified	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
D43.1 Brain, infratentorial	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
M95.0 Acquired deformity of nose	0.003	0.997	0.000
D38.3 Mediastinum	0.003	0.997	0.000
M84.03 Malunion of fracture (Forearm)	0.000	0.997	0.003
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.997	0.003
D41.9 Urinary organ, unspecified	0.003	0.997	0.000
D41.7 Other urinary organs	0.003	0.997	0.000
D41.3 Urethra	0.003	0.997	0.000
Z71.6 Tobacco abuse counselling	0.003	0.997	0.000
D41.4 Bladder	0.003	0.997	0.000
M84.08 Malunion of fracture (Other)	0.000	0.997	0.003
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.997	0.003
R41.3 Other amnesia	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.002	0.997	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.003	0.997	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.003	0.997	0.000
Z71.7 Human immunodeficiency virus [HIV] counselling	0.003	0.997	0.000
Z71.5 Drug abuse counselling and surveillance	0.003	0.997	0.000
Z71.0 Person consulting on behalf of another person	0.003	0.997	0.000
D39.7 Other female genital organs	0.003	0.997	0.000
D41.2 Ureter	0.002	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.997	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.000	0.997	0.003
M84.05 Malunion of fracture (Pelvic region and thigh)	0.000	0.997	0.003
D39.9 Female genital organ, unspecified	0.002	0.997	0.000
D39.2 Placenta	0.002	0.997	0.000
Z71.9 Counselling, unspecified	0.003	0.997	0.000
M84.09 Malunion of fracture (Site unspecified)	0.000	0.997	0.002
M84.00 Malunion of fracture (Multiple sites)	0.000	0.997	0.002
N71 Inflammatory disease of uterus, except cervix	0.000	0.997	0.003
L21.9 Seborrhoeic dermatitis, unspecified	0.000	0.997	0.002
O90.9 Complication of the puerperium, unspecified	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.001
R82 Other abnormal findings in urine	0.000	0.998	0.002
D68.9 Coagulation defect, unspecified	0.002	0.998	0.000
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.998	0.002
R82.4 Acetonuria	0.000	0.998	0.002
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.998	0.002
D44.7 Aortic body and other paraganglia	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
D39.0 Uterus	0.002	0.998	0.000
D41.0 Kidney	0.002	0.998	0.000
M84.06 Malunion of fracture (Lower leg)	0.000	0.998	0.002
D44.6 Carotid body	0.002	0.998	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.002	0.998	0.000
D44.5 Pineal gland	0.002	0.998	0.000
D44.2 Parathyroid gland	0.002	0.998	0.000
O90 Complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.998	0.002
O85 Puerperal sepsis	0.000	0.998	0.002
D44.9 Endocrine gland, unspecified	0.002	0.998	0.000
K04.8 Radicular cyst	0.000	0.998	0.002
N71.0 Acute inflammatory disease of uterus	0.000	0.998	0.002
O90.1 Disruption of perineal obstetric wound	0.000	0.998	0.002
S42.20 Fracture of upper end of humerus (closed)	0.002	0.998	0.000
D44.8 Pluriglandular involvement	0.002	0.998	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
K14.9 Disease of tongue, unspecified	0.000	0.998	0.002
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.002	0.998	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.998	0.002
O62.3 Precipitate labour	0.002	0.998	0.000
N35 Urethral stricture	0.002	0.998	0.000
M95.3 Acquired deformity of neck	0.002	0.998	0.000
D67 Hereditary factor IX deficiency	0.002	0.998	0.000
D44.1 Adrenal gland	0.002	0.998	0.000
Z71.8 Other specified counselling	0.002	0.998	0.000
O90.2 Haematoma of obstetric wound	0.000	0.998	0.002
E26.0 Primary hyperaldosteronism	0.000	0.998	0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
R82.3 Haemoglobinuria	0.000	0.998	0.002
R82.2 Biliuria	0.000	0.998	0.002
R82.0 Chyluria	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
O85-O92 Complications predominantly related to the puerperium	0.000	0.998	0.002
G59.0 Diabetic mononeuropathy	0.000	0.998	0.002
O62 Abnormalities of forces of labour	0.002	0.998	0.000
O92 Other disorders of breast and lactation associated with childbirth	0.000	0.998	0.002
D44.4 Craniopharyngeal duct	0.002	0.998	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.002	0.998	0.000
O87.8 Other venous complications in the puerperium	0.000	0.998	0.002
M84.01 Malunion of fracture (Shoulder region)	0.000	0.998	0.002
R82.1 Myoglobinuria	0.000	0.998	0.002
R59 Enlarged lymph nodes	0.002	0.998	0.000
S82.20 Fracture of shaft of tibia (closed)	0.002	0.998	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.998	0.002
M95.2 Other acquired deformity of head	0.002	0.998	0.000
R25.1 Tremor, unspecified	0.002	0.998	0.000
O87 Venous complications in the puerperium	0.000	0.998	0.002
D69.5 Secondary thrombocytopenia	0.002	0.998	0.000
O92.2 Other and unspecified disorders of breast associated with childbirth	0.000	0.998	0.002
Y42.5 Other oestrogens and progestogens	0.000	0.998	0.002
D44.3 Pituitary gland	0.002	0.998	0.000
N71.1 Chronic inflammatory disease of uterus	0.000	0.998	0.002
O90.5 Postpartum thyroiditis	0.000	0.998	0.002
O90.4 Postpartum acute renal failure	0.000	0.998	0.002
O90.3 Cardiomyopathy in the puerperium	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
O62.9 Abnormality of forces of labour, unspecified	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
O91 Infections of breast associated with childbirth	0.000	0.998	0.002
D44.0 Thyroid gland	0.001	0.998	0.000
M95.1 Cauliflower ear	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
H53.8 Other visual disturbances	0.002	0.998	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.002	0.998	0.000
M95.8 Other specified acquired deformities of musculoskeletal system	0.002	0.998	0.000
M95.5 Acquired deformity of pelvis	0.002	0.998	0.000
M95.4 Acquired deformity of chest and rib	0.002	0.998	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.002	0.998	0.000
O92.1 Cracked nipple associated with childbirth	0.000	0.998	0.002
J06.9 Acute upper respiratory infection, unspecified	0.000	0.998	0.002
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.998	0.001
K83.1 Obstruction of bile duct	0.002	0.998	0.000
O91.1 Abscess of breast associated with childbirth	0.000	0.998	0.002
D39.1 Ovary	0.002	0.998	0.000
N35.0 Posttraumatic urethral stricture	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.000	0.998	0.002
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.998	0.002
R85.5 Abnormal microbiological findings	0.002	0.998	0.000
Z96.0 Presence of urogenital implants	0.000	0.998	0.002
O88 Obstetric embolism	0.000	0.998	0.002
O92.7 Other and unspecified disorders of lactation	0.000	0.998	0.002
O92.6 Galactorrhoea	0.000	0.998	0.002
O92.5 Suppressed lactation	0.000	0.998	0.002
O92.4 Hypogalactia	0.000	0.998	0.002
O92.3 Agalactia	0.000	0.998	0.002
O92.0 Retracted nipple associated with childbirth	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.000	0.998	0.001
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.002	0.998	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.002	0.998	0.000
O87.0 Superficial thrombophlebitis in the puerperium	0.000	0.998	0.002
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.001	0.998	0.000
G54.9 Nerve root and plexus disorder, unspecified	0.002	0.998	0.000
O87.3 Cerebral venous thrombosis in the puerperium	0.000	0.998	0.001
O87.1 Deep phlebothrombosis in the puerperium	0.000	0.998	0.001
O86 Other puerperal infections	0.000	0.998	0.002
O87.9 Venous complication in the puerperium, unspecified	0.000	0.998	0.001
O90.0 Disruption of Caesarean section wound	0.000	0.998	0.001
D69 Purpura and other haemorrhagic conditions	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.002	0.998	0.000
K63.2 Fistula of intestine	0.000	0.998	0.002
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.001	0.998	0.000
O89 Complications of anaesthesia during the puerperium	0.000	0.998	0.001
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
O62.8 Other abnormalities of forces of labour	0.001	0.998	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.001	0.998	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
O91.0 Infection of nipple associated with childbirth	0.000	0.998	0.001
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.001	0.998	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.001	0.998	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.001	0.998	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.001	0.998	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.001	0.998	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations